Drug Profile
Research programme: aminoquinolones - Immtech/Tulane University
Latest Information Update: 16 Aug 2007
Price :
$50
*
At a glance
- Originator Tulane University
- Class
- Mechanism of Action
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Suspended Malaria